MeVis Medical Solutions AG develops software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company provides image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. It also offers X-ray based radiography procedures, including computed tomography, mammography/digital tomosynthesis, magnetic resonance imaging, and digital sonography; as well as provides services in the field of software programming for medical technology companies, which comprise provision of software developers, product and project managers, application specialists, and test engineers. In addition, the company provides three-dimensional technical visualizations; and interactive online training to enhance the diagnostic skills of clinicians; and internet-based special applications in teleradiology. The company was founded in 1997 and is based in Bremen, Germany. MeVis Medical Solutions AG is a subsidiary of Varex Imaging Corporation.
Frequently asked questions
What sector does MeVis Medical Solutions AG (M3V) operate in?
MeVis Medical Solutions AG belongs to the Healthcare sector and operates in the Health Information Services industry.
What is MeVis Medical Solutions AG (M3V) current stock price?
As of the latest data, MeVis Medical Solutions AG stock price is €19.90, with a previous close of €21.20. MeVis Medical Solutions AG lost -€1.30 in the last trading session, representing a -6.13% loss.
What is MeVis Medical Solutions AG (M3V) current market capitalization?
MeVis Medical Solutions AG market cap is approximately 36.22 million.
What is MeVis Medical Solutions AG (M3V) Earnings Per Share (EPS)?
The trailing EPS is €0.42.
What is MeVis Medical Solutions AG (M3V) Price-to-Earnings (P/E) ratio?
MeVis Medical Solutions AG current P/E ratio is 47.38.
Does MeVis Medical Solutions AG (M3V) pay dividends?
Yes. MeVis Medical Solutions AG pays annual dividends with an annualized yield of 4.77% and an estimated annual payout of €0.95 per share.
When is the next ex-dividend date for MeVis Medical Solutions AG (M3V)?
The next ex-dividend date is scheduled for March 20, 2027.
What is MeVis Medical Solutions AG (M3V) beta (volatility) score?
MeVis Medical Solutions AG has a beta of -0.020, indicating lower volatility than the overall market.